The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 06, 2004

Filed:

Oct. 01, 2002
Applicant:
Inventors:

Christopher L. Parks, Boonton, NJ (US);

Mohinderjit S. Sidhu, Scotch Plains, NJ (US);

Stephen A. Udem, New York, NY (US);

Gerald R. Kovacs, Morristown, NJ (US);

Assignee:

Wyeth Holdings Corporation, Madison, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12P 2/106 ; C12Q 1/70 ; C12Q 1/68 ; A61K 3/900 ; A61K 3/912 ;
U.S. Cl.
CPC ...
C12P 2/106 ; C12Q 1/70 ; C12Q 1/68 ; A61K 3/900 ; A61K 3/912 ;
Abstract

This invention relates to improved methods for producing nonsegmented, negative-sense, single-stranded RNA viruses of the Order designated Mononegavirales virus, including embodiments relating to methods of producing such viruses as attenuated and/or infectious viruses, such as Measles virus (MV) and respiratory syncytial virus (RSV). One method for producing a recombinant virus from the Order Mononegavirales comprises (a) in at least one host cell, conducting transfection of a rescue composition which comprises (i) a transcription vector comprising an isolated nucleic acid molecule which comprises polynucleotide sequence encoding a genome or antigenome of a nonsegmented, negative-sense, single stranded RNA virus of the Order Mononegavirales and (ii) at least one expression vector which comprises at least one isolated nucleic acid molecule encoding the trans-acting proteins necessary for encapsidation, transcription and replication; in a host cell under conditions sufficient to permit the co-expression of these vectors and the production of the recombinant virus; (b) heating the transfected rescue composition to an effective heat shock temperature under conditions sufficient to increase the recovery of the recombinant virus; and optionally, (c) harvesting the resulting recombinant virus.


Find Patent Forward Citations

Loading…